The Global Defibrillator Market is likely to expand considerably in the coming years due to the increasing incidence of out of hospital cardiac arrests. According to a report published by Fortune Business Insights, titled “Defibrillator: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 9,836.8 Mn in 2018. Fortune Business Insights states that the market will be valued at US$ 14,806.4 Mn by 2026, thereby exhibiting a CAGR of 5.3% during the forecast period.
- Implantable Cardioverter Defibrillator (ICD)
. Transvenous ICD
. Single Chamber ICD
. Dual Chamber ICD
. CRT-D (cardiac resynchronization therapy- defibrillator)
. Subcutaneous ICD
- External Defibrillator
. Automated External Defibrillator (AED)
. Manual and Semi-automatic External Defibrillator
. Wearable External Defibrillator
By End User
- Hospitals & Clinics
- Ambulatory, Schools and other Public Places
- North America (USA and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Rest of the World
According to the National Institutes of Health, an estimated 450,000 people succumbed to cardiac arrests in 2016. Coupled with a low survival rate, increasing awareness about cardiac arrests by private as well as public organizations is boosting the global defibrillator market. The increasing death rate of cardiac arrests in emerging nations has created a demand for defibrillators, globally. The exceptional properties possessed by defibrillators have led their rising uptake and this is likely to have a positive impact on the global defibrillators market.
Boston Scientific Proposes a Defibrillator with 70% More Pacing Options
Boston Scientific receives FDA approval for its newest range of defibrillators, designed to better patient care. The company received approvals for Dynagen Mini and Inogen Mini, along with Dynagen X4 and Inogen X4. The company claims that the X4 lines of defibrillators offer 70% more pacing options for gathering elevated threshold levels. The size of these devices are what differentiates them from its counterparts and it has created a rising uptake within end users. The company has submitted on its website that these devices are approximately 20% smaller than the existing devices, produced by its counterparts. The approvals for Boston Scientific’s latest devices is likely to enable the growth of the global market in the forthcoming years.
FDA Approves Wearable Defibrillator for Children
The FDA approved ‘LifeVest’ defibrillator has been successful ever since it was announced in 2017. The LifeVest was launched as a wearable device, suitable for children at the risk of sudden cardiac arrest. The device consists of an electrode belt and a cloth that surrounds the chest of the patient using it. Additionally, the device also makes use of a monitor that is used for real time analysis. The efficacy of the device has lifted the otherwise moderately rising defibrillator market. The device provides a shock to the heart, whenever a failure is detected, allowing it to restore its heartbeat. LifeVest has a positive outcome on the global defibrillators market and is likely to enable growth of the market in the coming years.
More Trending Topics From Fortune Business [email protected]